GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Kaibao Pharmaceutical Co Ltd (SZSE:300039) » Definitions » 5-Year Dividend Growth Rate

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) 5-Year Dividend Growth Rate : -15.40% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Shanghai Kaibao Pharmaceutical Co 5-Year Dividend Growth Rate?

Shanghai Kaibao Pharmaceutical Co's Dividends per Share for the three months ended in Mar. 2024 was ¥0.00.

During the past 12 months, Shanghai Kaibao Pharmaceutical Co's average Dividends Per Share Growth Rate was 20.00% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -15.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -15.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -10.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shanghai Kaibao Pharmaceutical Co was 213.30% per year. The lowest was -33.10% per year. And the median was -10.35% per year.

Shanghai Kaibao Pharmaceutical Co's Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Shanghai Kaibao Pharmaceutical Co's Dividend Yield % is 1.84%.

Good Sign:

Shanghai Kaibao Pharmaceutical Co Ltd stock dividend yield is close to 2-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate falls into.



Shanghai Kaibao Pharmaceutical Co 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Shanghai Kaibao Pharmaceutical Co  (SZSE:300039) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shanghai Kaibao Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.086
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Shanghai Kaibao Pharmaceutical Co was 1.09. The lowest was 0.18. And the median was 0.42.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Shanghai Kaibao Pharmaceutical Co Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
CNY 0.1000002024-06-192024-06-182024-06-19Cash DividendannuallyCNY:CNY 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Shanghai Kaibao Pharmaceutical Co's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.1/5.44
=1.84 %

Current Share Price is ¥5.44.
Shanghai Kaibao Pharmaceutical Co's Dividends per Share for the trailing twelve months (TTM) ended in Today is ¥0.1.

During the past 13 years, the highest Dividend Yield of Shanghai Kaibao Pharmaceutical Co was 4.34%. The lowest was 0.31%. And the median was 1.54%.

Good Sign:

Shanghai Kaibao Pharmaceutical Co Ltd stock dividend yield is close to 2-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Kaibao Pharmaceutical Co 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Kaibao Pharmaceutical Co's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Business Description

Traded in Other Exchanges
N/A
Address
88 Chengpu Road, Shanghai Industrial Comprehensive Development Zone, Shanghai, CHN, 201401
Shanghai Kaibao Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in research, development, production, and sales of modern Chinese medicine. The company produces traditional Chinese medicines in the form of solid dosage, oral liquids, and small volume injections. Its main product is Tanreqing injection is mainly used for pneumonia, acute and chronic bronchitis and upper respiratory tract infection.
Executives
Liu Shao Yong Supervisors
Ren Li Wang Secretary Dong
Zhang Tao Executives
Mu Jing Wei Director
Li Xiu Hai Directors, executives
Zhang Lian Xin Supervisors
Han Jing Independent director
Wang Guo Ming Directors, executives
Wang Chong Bang Executives
Liu Yi Shan Director
Li Qing Wei Independent director
Mu Lai An Director
Zhu Ying Jun Executives
Chang Qing Ling Supervisors
Zhang Peng Director

Shanghai Kaibao Pharmaceutical Co (SZSE:300039) Headlines

No Headlines